Exane Derivatives’s Trane Technologies TT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$2.73K Hold
21
﹤0.01% 417
2022
Q1
$3.21K Hold
21
﹤0.01% 725
2021
Q4
$4.24K Sell
21
-778
-97% -$146K ﹤0.01% 627
2021
Q3
$138K Sell
799
-70
-8% -$13.5K 0.03% 480
2021
Q2
$166K Sell
869
-295
-25% -$52.6K 0.04% 445
2021
Q1
$193K Hold
1,164
0.06% 303
2020
Q4
$169K Buy
+1,164
New +$161K 0.05% 332
2019
Q3
Sell
-5,839
Closed -$739K 696
2019
Q2
$739K Buy
5,839
+5,828
+52,982% +$697K 0.13% 128
2019
Q1
$1.19K Sell
11
-10,163
-100% -$1.03M ﹤0.01% 486
2018
Q4
$928K Sell
10,174
-31,523
-76% -$3.1M 0.17% 128
2018
Q3
$4.26M Buy
41,697
+15,599
+60% +$1.52M 0.8% 25
2018
Q2
$2.34M Buy
+26,098
New +$2.29M 0.39% 54
2017
Q3
Sell
-1
Closed -$91 646
2017
Q2
$91 Hold
1
﹤0.01% 572
2017
Q1
$81 Hold
1
﹤0.01% 500
2016
Q4
$75 Hold
1
﹤0.01% 560
2016
Q3
$68 Sell
1
-183,298
-100% -$12.2M ﹤0.01% 551
2016
Q2
$11.7M Buy
+183,299
New +$11.8M 1.93% 23

Other funds holding TT

Exane Derivatives's TT Position: Q2 2022 in Review

Exane Derivatives held its Trane Technologies (TT) position steady in Q2 2022 at 21 shares worth $2.73K. The position accounts for ﹤0.01% of the portfolio, ranked #417.

Exane Derivatives first reported a position in TT in Q2 2016 and has held it in 17 quarters since. The position peaked at $11.7M in Q2 2016. 903 funds tracked by Wall St. Rank hold TT as of Q2 2022.

  • Exane Derivatives held 21 shares of Trane Technologies worth $2.73K as of Q2 2022.
  • Exane Derivatives left its Trane Technologies share count unchanged in Q2 2022.
  • Trane Technologies made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #417 holding.
  • Exane Derivatives first reported a position in Trane Technologies in Q2 2016 and has held it in 17 quarters since.
  • Exane Derivatives's Trane Technologies position peaked at $11.7M in Q2 2016.
  • 903 funds tracked by Wall St. Rank held Trane Technologies as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.